CBCT Intervention
BehavioralThe training consists of six weekly sessions. The participant will receive six guided meditation audio, relative to each session, to practice during the week.
NCT Number: NCT03737084
The hematopoietic stem cell transplant (HSCT) experience is emotionally and physically stressful for cancer patients who undergo this procedure. This study aims to evaluate the effects of Cognitively-Based Compassion Training (CBCT) on depression and anxiety symptoms, levels of resilience, hope and self-compassion in patients undergoing HSCT and their caregivers. As well as assessing the effects of CBCT on clinical conditions in patients and cortical activity and heart rate variability in caregivers.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
The study hopes to show the positive effects of compassion training in patients and their caregivers.
Overall aim:
This study aims to evaluate the effects of Cognitively-Based Compassion Training (CBCT) on: depression and anxiety symptoms; levels of hope; resilience; mindfulness; self-compassion and quality of life. The study also aims to demonstrate whether CBCT training has any effect on clinical parameters of transplanted patients, as well as whether it has an effect on cortical activity and heart rate variability inpatients and caregivers.
Specific objectives:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The training consists of six weekly sessions. The participant will receive six guided meditation audio, relative to each session, to practice during the week.
Time frame: baseline,1 week after intervention
Hospital Anxiety and Depression Scale (HADS). The scale consists of 14 items, 7 for anxiety (HADS-A) and 7 items for depression (HADS-D). The final score ranges from 0 to 21 points in each subscale, the higher the score, the greater the symptoms of anxiety or depression (Zigmond and Snaith, 1983).
Time frame: baseline; 1 week after intervention.
Resilience Scale (RS). Developed by Wagnild and Young (Wagnild and Young, 1993). Composed of 25 items. The Resilience Scale was applied to measure the degree of resilience. It measures two main factors: 'personal competence' (17 items) and 'acceptance of self and life' (8 items). The response scale ranges from 1 ('totally disagree') to 7 ('totally agree'). The total score ranges from 26 to 175 points. The higher the score the higher the level of resilience.
Time frame: baseline; 1 week after intervention.
Self-Compassion Scale. This is a 26-item scale that measures how one typically acts toward oneself in difficult times. These items were designed to assess how respondents perceive their actions toward themselves in difficult times and are rated using a Likert-type scale anchored from 1 (almost never) to 5 (almost always). The scale ranges from 26 to 130 points. The higher the score the higher the level of Self-Compassion. Developed by Kristin Neff.
Time frame: baseline; 1 week after intervention.
Perceived Stress Scale (PSS). This scale measures the degree to which individuals perceive situations as stressful. Composed of 14 items related to sensation. PSS scores are obtained by reversing the scores on the seven positive items, e.g., 0=4, 1=3, 2=2, etc., and then summing across all 14 items. Items 4, 5, 6, 7, 9, 10, and 13 are the positively stated items. A higher score indicates a higher level of Perceived Stress. The final score ranges from 0 to 56 points. Developed by Luft, 2007.
Time frame: baseline, 1 week after intervention
Measured by Near-Infrared Spectroscopy (NIRS), in an experiment using a paradigm of autobiographical events, remembering stressful and positive memories.
Time frame: baseline, 1 week after intervention
Measured from the cardiac activity record through a Polar® V800 heart monitor.
Hospital Israelita Albert Einstein
Other
Effects of the Cognitively-Based Compassion Training (CBCT) Adapted to Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) and Their Caregivers on Biological and Psychosocial Parameters
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06692478
Deconditioning, Hematopoietic Stem Cell Transplant
Phoenix, Arizona, United States
View Trial DetailsNCT07732361
Blood Platelet Disorders, Cytopenia
Boston, Massachusetts, United States
View Trial DetailsNCT04263597
Hematopoietic Stem Cell Transplant
Cincinnati, Ohio, United States
View Trial DetailsNCT04118530
Arrhythmias, Cardiac, Atrial Fibrillation
Philadelphia, Pennsylvania, United States
View Trial Details